Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.50MP/E –Yield –
Achieve Life Sciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Achieve Life Sciences's price to book ratio was 32.0× on Jul 31, 2026, against 8.8× a year earlier. Over the last 5 years it ranged from 1.5× to 250.9×, with a median of 4.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 32.0× | +24.2 |
| 2025 | Dec 31, 2025 | 7.8× | +4.0 |
| 2024 | Dec 31, 2024 | 3.9× | −17.7 |
| 2023 | Dec 29, 2023 | 21.6× | −1.2 |
| 2022 | Dec 30, 2022 | 22.8× | +20.7 |
| 2021 | Dec 31, 2021 | 2.1× | +1.0 |
| 2020 | Dec 31, 2020 | 1.1× | −9.4 |
| 2019 | Dec 31, 2019 | 10.6× | +2.2 |
| 2018 | Dec 31, 2018 | 8.4× | −279.7 |
| 2017 | Dec 29, 2017 | 288.1× | +287.1 |
| 2016 | Dec 30, 2016 | 1.0× | −0.5 |
| 2015 | Dec 31, 2015 | 1.5× | −0.5 |
| 2014 | Dec 31, 2014 | 2.0× | −2.4 |
| 2013 | Dec 31, 2013 | 4.4× | +0.1 |
| 2012 | Dec 31, 2012 | 4.3× | −0.2 |
| 2011 | Dec 30, 2011 | 4.5× | – |
See a number that looks wrong?